Promotor methylation: does it affect response to therapy in chronic hepatitis C (G4) or fibrosis?

Autor: N Zekri AR; Molecular Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt., Raafat AM; Molecular Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt., Elmasry S; Biochemistry Department, Faculty of Science, Cairo University, Cairo, Egypt., Bahnassy AA; Molecular Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt., Saad Y; Department of Endemic Medicine and Hepatology, Faculty of Medicine, Cairo University, Cairo, Egypt., Dabaon HA; Organic Chemistry Department, Faculty of Science, Cairo University, Cairo, Egypt., El-Kassas M; Department of Endemic Medicine and Hepatology, Faculty of Medicine, Cairo University, Cairo, Egypt., Shousha HI; Department of Endemic Medicine and Hepatology, Faculty of Medicine, Cairo University, Cairo, Egypt., Nassar AA; Molecular Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt., El-Dosouky MA; Biochemistry Department, Faculty of Science, Cairo University, Cairo, Egypt., Hussein N; Molecular Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt.

Publikováno v: Annals of hepatology [Ann Hepatol] 2014 Sep-Oct; Vol. 13 (5), pp. 518-24.